Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» ESMO: AstraZeneca wows with Imfinzi's 11-month survival edge in lung cancer
ESMO: AstraZeneca wows with Imfinzi's 11-month survival edge in lung cancer
ESMO: AstraZeneca wows with Imfinzi's 11-month survival edge in lung cancer
Submitted by
admin
on September 10, 2017 - 11:43am
Source:
Fierce Pharma
News Tags:
ESMO
AstraZeneca
Imfinzi
lung cancer
Headline:
ESMO: AstraZeneca wows with Imfinzi's 11-month survival edge in lung cancer
Do Not Allow Advertisers to Use My Personal information
